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Abstract Current genome-wide association studies
(GWAS) use commercial genotyping microarrays that can
assay over a million single nucleotide polymorphisms
(SNPs).ThenumberofSNPs isfurther boostedbyadvanced
statistical genotype-imputation algorithms and large SNP
databases for reference human populations. The testing of a
huge number of SNPs needs to be taken into account in the
interpretationofstatisticalsigniﬁcanceinsuchgenome-wide
studies, but this is complicated by the non-independence of
SNPs because of linkage disequilibrium (LD). Several pre-
vious groups have proposed the use of the effective number
of independent markers (Me) for the adjustment of multiple
testing,butcurrent methods ofcalculationforMeare limited
in accuracy or computational speed. Here, we report a more
robust and fast method to calculate Me. Applying this efﬁ-
cient method [implemented in a free software tool named
Genetic type 1 error calculator (GEC)], we systematically
examined the Me, and the corresponding p-value thresholds
requiredtocontrolthegenome-widetype1errorrateat0.05,
for 13 Illumina or Affymetrix genotyping arrays, as well as
for HapMap Project and 1000 Genomes Project datasets
which are widely used in genotype imputation as reference
panels. Our results suggested the use of a p-value threshold
of *10
-7 as the criterion for genome-wide signiﬁcance
for early commercial genotyping arrays, but slightly more
stringent p-value thresholds *5 9 10
-8 for current or
merged commercial genotyping arrays, *10
-8 for all
common SNPs in the 1000 Genomes Project dataset and
*5 9 10
-8 for the common SNPs only within genes.
Introduction
Genome-wideassociationstudies(GWAS)cannowdirectly
assay up to 2.5 million single nucleotide polymorphisms
(SNPs)usinghigh-throughputgenotypingarrays (Ragoussis
2009). The number of SNPs is further boosted by statistical
genotype-imputation algorithms that make use of large SNP
reference datasets such as the HapMap Project and 1000
Genomes Project (Anderson et al. 2008; Howie et al. 2009).
The number of SNPs is set to increase further with recent
advances in resequencing technology (Metzker 2010). The
testing of such huge numbers of SNPs results in a massive
multiple-testing burden in statistical analysis.
The Bonferroni correction, which resets the signiﬁcance
threshold from a to a/M in the presence of M independent
tests, is probably the most popular method for multiple-
testing adjustment. However, the Bonferroni correction
assumes independence among the tests considered, so that
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linkage disequilibrium (LD). Adjustment for multiple
testing by permutation appropriately takes account of
marker dependency and results in a more powerful test
(Pahl and Schafer 2010), but is computationally expensive.
There have been a number of attempts to extend the con-
ventional Bonferroni procedure to handle correlated tests,
by replacing the actual number of markers being tested (M)
by a smaller value called the effective number of inde-
pendent markers (Me). This results in a test-wise signiﬁ-
cance threshold of a0 ¼ a=Me; which controls the family-
wise error rate (FWER) at a. Conversely, the test-wise
error rate a0 is related to the family-wise error by a ¼
1  ð 1   a0Þ
Me   Mea0 Efforts were made to assess the
genome-wide signiﬁcance thresholds after Bonferroni
correction for early GWAS (Dudbridge and Gusnanto
2008; Pe’er et al. 2008). However, it is not known whether
these thresholds are still applicable to current or future
GWAS in which much more SNPs are assayed.
Several methods have been proposed for estimating Me
from the correlations between the genetic markers. Duggal
etal.(2008)suggested thesimplemethod ofcounting1SNP
per LD block in addition to all the SNPs outside of blocks.
Other proposed methods involved the eigenvalues of the LD
measure r
2 or Pearson correlation matrix of allele counts
calculated from all possible pairs of SNPs (Cheverud 2001;
Gao etal.2008;Liand Ji2005;Nyholt2004;Galwey2009).
Two of these methods used the variance of the eigenvalues
(k) to estimate Me (Cheverud 2001; Nyholt 2004). An
important limitation of these variance-based approaches is
that they do not result in additive Me estimates across con-
tiguoussetsofSNPs.LiandJi(2005)suggestedsummingthe
eigenvalues, after substituting 1 for the eigenvalues that are
greater than 1. While generally more accurate than the var-
iance-based approaches, this method can be both conserva-
tive and liberal in different situations (Li and Ji 2005). Gao
et al. suggested deﬁning Me as the number of eigenvalues
which can explain C% of the variation for SNP genotype
data. However, it is unclear how C should be set, as overly
large or small value of C would result in an FWER that is
overly conservative or liberal, respectively (2008). Galwey
(2009) proposed a measure of Me based on an eigenvalue
ratiofunction.MoskvinaandSchmidtsuggestedaformulato
approximate Me based on the conditional probability of a
Type1errorinonemarkergiventhetestoutcomeofasecond
marker (Moskvina and Schmidt 2008). Several studies have
concluded that the available measures of Me were not sufﬁ-
ciently accurate as a valid substitute for a permutation pro-
cedure(Hanetal.2009;Salyakinaetal.2005;Galwey2009).
Here we propose a new method to more accurately and
rapidly estimate the effective number of independent tests,
Me, from a given set of SNPs. The ratio of Me to the actual
number of SNPs in a genotyping array is suggested as an
index of the tagging efﬁciency of an array. Extensive
simulation studies based on both artiﬁcial and real LD
patterns were conducted to compare the performance of
this method against ﬁve alternative approaches. We then
systematically investigated the Me for 13 popular com-
mercial genotyping arrays from Illumina and Affymetrix,
as well as for the HapMap Project and 1000 Genomes
Project genotype datasets which are widely used as refer-
ence panels in genotype imputation. From this, we provide
a series of suggested Bonferroni p-value thresholds to
correct for the multiple-testing burden in different popu-
lations, when using these arrays and imputed datasets.
Methods and materials
Construction of a new measure of the effective number
of independent tests
Our method is similar to that of Li and Ji (2005), except
that the used eigenvalues are those of the correlation matrix
of association test p values, rather than the correlation
matrix of allele counts, between SNPs. In a previous paper
(Li et al. 2011), we described a polynomial approximation
that allows the correlation matrix of association test
p values to be calculated from the correlation matrix of
allele counts. If the eigenvalues of the correlation matrix of
M association test p values are denoted by ki; then the
effective number of tests, Me is estimated to be M  
PM
i¼1 Iðki [1Þðki   1Þ ½  ; where I(x) is an indicator func-
tion. The second part of this formula estimates the redun-
dant number of tests as a result of marker dependency. The
p-value threshold to control FWER to a, using Me in a
Bonferroni procedure, would then be a=Me. The ratio
Re = Me/M, called ‘‘effective ratio’’ for convenience,
measures the extent that the M markers are non-redundant.
A divide-and-conquer algorithm was developed to speed
up the calculation of eigenvalues of large correlation
matrices. SNPs on a chromosome can be partitioned into
multiple loose LD blocks. Within a block, a SNP has strong
or moderate LD with at least one other SNP while SNPs in
different LD blocks are in weak LD (say, r
2\0.1). The-
oretically, assume a large correlation matrix, P ¼
A 0
0 B
  
; has an eigenvalue, k; and an associated eigen-
vector X
Y
  
. According to the deﬁnition of eigenvalue,
A 0
0 B
  
X
Y
  
¼ AX
BY
  
¼ kX
kY
  
. Therefore, AX ¼ kX and
748 Hum Genet (2012) 131:747–756
123BY ¼ kY. This indicates that matrixes P, A and B share the
same eigenvalues and the LD block partition will not
change the eigenvalues and thus the resulting Me, provided
the blocks are independent. The Me of whole genome is
equal to the summation of the Me calculated within each
LD block. This divide-and-conquer strategy substantially
speeds up the analysis by avoiding calculating eigenvalues
in a huge matrix with thousands of rows and columns,
although, in principle, if blocks cannot be formed the
proposed measure of Me could still be implemented.
Datasets
Local genotype dataset
In the simulation study, we used a genotype dataset of
2,514 Chinese subjects typed by the Illumina Human610-
Quad BeadChip. This sample was originally prepared for
several independent disease-gene mapping projects [(Kung
et al. 2010) and unpublished data]. After standard quality
control procedures of GWAS scan for common variants,
473,931 SNPs were left in the simulation analysis.
HapMap LD dataset
We downloaded the latest version of pair-wise LD data (r
2)
of the 11 HapMap panels (http://hapmap.ncbi.nlm.nih.gov/
downloads/ld_data/latest/, Release 27). For the JPT, CHB,
CEU and YRI panels, this release merged SNPs of phases
I ? II ? III and had more SNPs than other 7 panels which
entered the HapMap Project at phase III. Therefore, we
used the LD data of the 4 panels to derive the Me on the 13
commercial genotyping arrays. The numbers of unique
SNPs contained in the 4 LD dataset for JPT, CHB, CEU
and YRI panels were 2,509,881, 2,554,939, 2,776,528 and
3,114,362, respectively. But to provide a reference for
GWAS imputation in more populations, we estimated the
Me and corresponding p-value thresholds in all of the 11
panels as well.
1000 Genomes Project genotype dataset
We downloaded genotypes of 1000 Genomes Project
(released by August 2010) from the website of MACH
(http://www.sph.umich.edu/csg/abecasis/MACH/download/).
In this dataset, there were total 651 individuals separated in
three different panels according to ancestry, ASN (Asian,
194), EUR (European, 283), and AFR (African, 174). The
numbers of overall SNPs in the three panels are 10,832,281
(ASN), 11,914,767 (EUR), and 17,042,857 (AFR), respec-
tively. However, only around half of the SNPs have the
minor allele frequencies over 0.05. We estimated the Me
among SNPs with minor allele frequencies C0.05 because
SNPs with too small minor allele frequency are generally
underpowered in GWAS.
Examining the relationship between LD r
2
and correlation of p values from association tests
Genotype data of two bi-allelic SNPs were simulated for a
number of subjects, for a set of LD coefﬁcients, r, and
allele frequencies, under Hardy–Weinberg equilibrium. For
a case–control study, we randomly assigned disease status
to generate 3,000 cases and 3,000 controls; for a quanti-
tative trait study the 6,000 subjects were randomly given
phenotypic scores sampled from the standard normal dis-
tribution N(0, 1). That is, we simulated no correlation
between trait/disease and genotype. An allelic association
test was then performed for each of the two SNPs in the
case–control study and the Wald test for parameters in a
linear regression model was used to examine association in
the quantitative trait study. The procedure was repeated
100,000 times to obtain 100,000 sets of p values, from
which the correlation coefﬁcient of the p values of the two
SNPs,q; was calculated. The allele frequencies and the LD
coefﬁcients, r (Hill and Robertson 1968), were incremented
in steps of 0.05 to generate a series of data points. Repeated
simulations using samples of different sizes were also
conducted.
The relationship between LD r
2 and p-value correlation
coefﬁcients was extrapolated by least-squares ﬁtting using
a 6th order polynomial function of the squared pair-wise
allelic correlation coefﬁcient,r02; in Microsoft Excel 2007.
We found that under the null hypothesis p-value correlation
coefﬁcient,q; can be accurately approximated by a 6th
order polynomial function of the squared pair-wise allelic
correlation coefﬁcient r
2 (coefﬁcient of determination
R
2 = 0.9987) (Supplementary Fig. 1), regardless of allele
frequencies, sample size and study design.
Comparison of type 1 error of various measures
by simulation and permutation
Given the LD patterns and allele frequencies (see supple-
mentary Table 1), a program based on the HapSim algo-
rithm (Montana 2005) was written to generate genotype
data under Hardy–Weinberg equilibrium. We simulated
regions with 1 LD block (6 SNPs), 2 LD blocks (10 SNPs),
6 LD blocks (30 SNPs) or 24 LD blocks (120 SNPs). We
considered the null model where no SNP had an effect on
disease risk. For each scenario, a population of 4,000,000
individuals was generated. A random sample of 3,000 cases
and 3,000 controls was drawn from the population, without
replacement, and subjected to the different methods of
multiple testing. Type 1 error rates under the different
Hum Genet (2012) 131:747–756 749
123scenarios were obtained from the proportion of simulated
datasets that resulted in at least one signiﬁcant p value (set
at 0.05), from 1,000 simulated populations.
We compared the performance of the proposed measure
to 4 different estimates of Me as well as the conventional
Bonferroni correction approach. A permutation procedure
was also carried out for the comparison. The four previous
proposed Me measures have been described in the ‘‘Intro-
duction’’. In the permutation procedure, the phenotypes of
subjects were permuted 1,000 times and the smallest SNP
p value in a region at each permutation was chosen to
generate the empirical distribution. The resulting permuted
p value is equal to the proportion of the generated p values
less than the observed one.
Examining type 1 error using a real dataset
The allelic association test was used to examine association
at each SNP with simulated disease status in the real
genotype dataset of 2,514 Chinese subjects. The pair-wise
LD coefﬁcients, r
2, were approximated by the square of
Pearson correlation of genotypes coded as the number of
minor alleles (0, 1 and 2). The Me and type 1 error were
assessed at ﬁve regions containing 100–300 SNPs in dif-
ferent chromosomes sampled randomly. SNPs with minor
allele frequency less than 0.05, Hardy–Weinberg equilib-
rium p value less than 0.001, or genotype call rate less than
90% were excluded for this analysis. Type 1 error rates for
these regions were obtained from the proportion of simu-
lated phenotype datasets that resulted in signiﬁcant p val-
ues (at FWER 0.05), from 50,000 simulated datasets.
Comparison of type 1 error using multivariate normal
distribution (MVN)
On each chromosome, we randomly draw 500 regions with
a random number of SNPs ranging from 2 to 100 in the
same sample of 2,514 Chinese subjects mentioned above.
At each region, Me was estimated by ﬁve different methods
and the corresponding p-value threshold, a0; for individual
SNPs to control the FWER (a) at 0.05, was calculated by
Bonferroni correction method, a0 ¼ a=Me. Given a0, the
FWER was calculated by the standard cumulative distri-
bution function of MVN 0;
P
ðÞ :
1  
Z  A
A
fðxÞdu ¼ 1  
Z  A
A
1
ð2pÞ
M=2 P
jj
1=2 exp½ 
1
2
ðx   lÞ
T
 
X  1
ðx   lÞ du;
where A ¼ U 1ða0=2Þ;...;U 1ða0=2Þ
   T
is a M dimension
vector and
P
is the genotypic Pearson correlation
coefﬁcient matrix of the M SNPs. We used the R package
mvtnorm (http://cran.r-project.org/web/packages/mvtnorm/
index.html) for the numerical integration of the MVN.
Estimating Me and genome-wide signiﬁcance
thresholds in 13 genotyping arrays
It was noted that some SNPs in the genotyping arrays were
not in the HapMap Project. For each array, a pair-wise r
2
was extracted into a subset from the HapMap LD dataset if
both of its SNPs appeared on the genotyping array. The Me
and effective ratio were ﬁrst estimated for SNPs in the
subset. The total Me of the genotyping array was then
approximated by the number of SNPs on the array multi-
plied by the effective ratio. The p-value thresholds for
genome-wide signiﬁcant and highly signiﬁcant association
were equal to 0.05 and 0.001 divided by the total Me of the
genotyping array.
Results
Comparison of FWER in simulated data
The proposed method was compared to several existing
methods as well as permutation testing (the gold standard)
by simulation studies. Genotypes were simulated according
to artiﬁcial LD patterns (Supplementary Table 1), and
phenotypes were randomly assigned. As shown in Table 1,
the use of the proposed Me for Bonferroni correction pro-
duced FWER values that are generally close to the correct
value of 0.05. As expected, standard Bonferroni correction
for M SNPs is conservative. The correction based on
Nyholt’s Me was liberal when there is only one LD block,
but conservative in the multiple-LD-block scenarios. The
Li and Ji (2005) method was liberal in all the simulated
situations, while the Moskvina and Schmidt (2008) method
was slightly conservative in the one-block scenario but
becamelessconservativeinthemultiple-LD-blockscenarios.
Generally speaking, the type 1 error rates of Moskvina and
Schmidt (2008), Galwey (2009), and the proposed method,
along with those obtained via permutation, were comparable
in the simulated dataset.
Comparison of FWER in real data
We further examined the family-wise type I error rates of
the modiﬁed Bonferroni procedure by Me in a real GWAS
genotype dataset, where the phenotypes were re-assigned at
random. The real GWAS data used were on a sample of
2,514 Chinese subjects typed by the Illumina Human610-
Quad BeadChip. Five regions on different chromosomes
were randomly chosen for an empirical validation.
750 Hum Genet (2012) 131:747–756
123As shown in Table 2, the proposed measure of Me led to
FWERs much closer to the nominal a = 0.05 for all
regions in 50,000 simulated datasets. The simple Bonfer-
roni correction for number of SNPs was conservative, as
expected, as was the Bonferroni correction using Nyholt’s
Me. The methods of Li and Ji (2005) and Galwey (2009)
resulted in quite liberal FWERs. The FWERs based on
Moskvina and Schmidt (2008) were only slightly more
liberal than those based on our new method.
Comparison of FWER via MVN
For some common tests of association, the vector of test
statistics for a single trait over multiple markers asymptoti-
callyfollowsaMVN,orcanbetransformedtofollowaMVN
(Lin 2005; Seaman and Muller-Myhsok 2005); the covari-
ance matrix of this MVN can be approximated from the
matrix of correlation coefﬁcients between the markers
(Moskvina and Schmidt 2008; Han et al. 2009; Seaman and
Muller-Myhsok 2005; Conneely and Boehnke 2007). Given
a fully characterized MVN, the FWER for any speciﬁed
SNP-wise error rate can be calculated by multivariate inte-
gration. However, this is only feasible for a limited number
of SNPs because of the computational burden in calculating
the probabilities from a large-dimensional MVN. We ran-
domly drew 500 genomic regions on each of the 22 auto-
somes and the X chromosome from the real GWAS dataset
mentionedabove.Thenumberofmarkerswithineachregion
was random, ranging from 2 to 100. At each region, the ﬁve
different methods were used to estimate Me and to calculate
the test-wise p-value threshold required to obtain a nominal
FWER of 0.05. An estimate of the FWER corresponding to
each test-wise p-value threshold is then obtained from the
MVN. Figure 1 shows a Box plot of the MVN-derived
FWER for the different methods over the 11,500 randomly
selected regions. The proposed method of estimating Me
appears to give MVN-derived FWERs that agree most clo-
sely with the nominal level of 0.05, with least bias and small
variance (Fig. 1). Consistent with the results obtained via
simulation and permutation, the Bonferroni correction using
Nyholt’s Me was generally conservative; the methods of Li
and Ji (2005) and Galwey (2009) resulted in liberal FWERs,
and all three have larger variance across genomic regions.
The FWERs based on Moskvina and Schmidt (2008) were
slightly more liberal but had comparable variance as the
proposed method.
Table 1 Empirical family-wise type 1 error rates (percentages) of alternative multiple testing corrections in simulated datasets
#SNP Bonferroni
for # SNP
Nyholt
(2004)
Li and Ji (2005) Moskvina
and Schmidt (2008)
Galwey
(2009)
Permutation Proposed Me
6 2.14 6.10 5.94 4.02 4.68 4.95 4.81
10 2.70 3.82 6.24 4.45 4.96 4.98 5.01
30 2.84 3.11 6.59 4.67 5.22 4.91 5.28
120 2.89 3.06 6.80 4.94 5.56 4.74 5.60
The nominal FWER is 0.05. We simulated 4 different LD patterns, in which a region may have 1 LD block (including 6 SNPs), 2 LD blocks
(including 10 SNPs), 6 LD blocks (including 30 SNPs) and 24 LD blocks (including 120 SNPs), respectively, 40,000 replicates for each scenario.
See Supplementary Table 1 for the LD patterns
Table 2 Family-wise error rates and effective number of independent tests in real genotype datasets
Chromosome Position
a The observed Nyholt (2004) Li and Ji (2005) Moskvina and Schmidt
(2008)
Galwey (2009) Proposed Me
#SNP Error #SNP Error #SNP Error #SNP Error #SNP Error #SNP Error
1 5733711
6877920
137 2.74% 128.8 2.97% 52.0 6.56% 63.1 5.48% 48.7 7.04% 68.5 5.16%
2 105304539
106766191
271 3.31% 264.7 3.40% 110.0 7.45% 147.1 5.81% 100.1 8.01% 159.3 5.43%
3 178265666
179728246
186 2.97% 180.8 3.06% 85.0 6.40% 99.3 5.54% 78.3 6.84% 106.7 5.11%
6 100078150
102098421
282 2.68% 271.7 2.78% 88.0 7.74% 126.2 5.66% 78.6 8.51% 137.3 5.21%
21 30821453
31663481
118 3.01% 113.2 3.14% 51.0 6.86% 62.9 5.73% 48.8 7.08% 68.1 5.26%
a The coordinates of NCBI Human Reference Genome Build 36.3 was used to denote the regions. The 5 regions were randomly selected. The
Nominal FWER is 0.05; 50,000 simulated replicates were produced for each region
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123Estimating Me and genome-wide signiﬁcance
thresholds in 13 genotyping arrays
Applying the proposed method, we systematically esti-
mated Me for 7 Illumina and 6 Affymetrix genotyping
arrays, which have been widely used in GWAS in various
populations. The r
2 values in the HapMap LD dataset
(released on April 19, 2009) were used to calculate p-value
correlation coefﬁcients. Similar to the criteria proposed for
genome-wide linkage studies (Lander and Kruglyak 1995),
we calculated p-value thresholds for two genome-wide
signiﬁcance levels, signiﬁcant association, and highly sig-
niﬁcant association, in which the FWER per scan are 0.05
and 0.001, respectively. Table 3 shows results based on
HapMap CEU LD dataset. The thresholds for genome-wide
signiﬁcant association for all genotyping arrays (except for
the Illumina HumanOmni2.5) range from 8.21 9 10
-8 to
1.11 9 10
-6, which are all slightly less stringent than the
widely-adopted one, 5.0 9 10
-8. An association scan
based on the densest Affymetrix array requires a p-value
threshold of 1.08 9 10
-7 to declare a signiﬁcant hit and
the corresponding threshold for Illumina HumanHap 1 M
is 8.21 9 10
-8. When combining all of the six Affymetrix
arrays (1,011,854 unique SNPs in total), the p-value
threshold for signiﬁcant association is 1.04 9 10
-7. The
Illumina HumanOmni2.5 seems to have an efﬁcient design
for effective SNPs. Its effective ratio is comparable with
the Illumina HuamHap 1 M although it has doubled
the SNP amount. When all of the seven Illumina arrays
were combined, the p-value threshold turned out to be
*3.5 9 10
-8. This amount of markers often happens in
GWAS with genotype imputation, particularly in meta-
analysis of GWAS. Consistent with observation in Barrett
and Cardon (2006), Illumina arrays have larger effective
ratio and require more stringent p-value thresholds to
declare a signiﬁcant ﬁnding than the Affymetrix arrays
with similar number of SNPs. Results based on the Hap-
Map CHB, JPT and YRI LD datasets are shown in Sup-
plementary Table 2. Similarly, except for the Illumina
HumanOmni2.5, the thresholds for genome-wide signiﬁ-
cant association using the other available genotyping arrays
are all slightly less stringent than the widely adopted
threshold, 5.0 9 10
-8.
Estimating Me and signiﬁcance thresholds in datasets
of HapMap and 1000 Genomes Project
We then measured the Me in datasets of HapMap and 1000
Genomes project. As shown in Table 4, although the
number of unique SNPs in the HapMap LD dataset is over
2.5 million in the JPT, CHB and CEU panels, the Me is less
than 1 million and the ratio of Me to the observed number
(i.e., the effective ratio) is low, ranging from 0.26 to 0.30.
The p-value thresholds for signiﬁcant association are looser
than 5.0 9 10
-8. The YRI panel has both the largest
number of SNPs and effective ratio in the HapMap data,
which makes the stringent p-value threshold 3.44 9 10
-8.
Supplementary Table 3 shows the estimation results in the
other 7 HapMap panels. There are only around 1.5 million
SNPs in each panel and the effective ratios range from 0.41
Fig. 1 Box plot of MVN-
derived FWERs for ﬁve
different methods. For each
method, the nominal FWER was
set to be 0.05. The bottom and
top of each box mark the 25th
and 75th percentile,
respectively, and the band in the
box denotes the 50th percentile.
The lines above and below each
box denote the upper and lower
1.5 interquartile range (IQR)
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123to 0.65. However, the p-value thresholds of signiﬁcant
association are still close to 5.0 9 10
-8 in four panels
(LWK, MKK, ASW and MEX). The CHD panel has the
smallest number of SNPs and its p-value threshold for
signiﬁcant association is close to 10
-7.
The 1000 Genomes Project samples are divided into
three panels according to their population ancestry. The
common SNPs with minor allele frequency over 0.05 in the
1000 Genomes Project is over twice as large as the number
of SNPs in the HapMap data. The effective ratios in the
1000 Genomes Project datasets of ASN and EUR panel are
similar to that in the HapMap dataset of the corresponding
populations although the amount of SNPs of the former is
much more than that of the latter. The effective ratio in the
1000 Genomes Project AFR panel is smaller than that of
HapMap YRI panel. The large Me in the 1000 Genomes
Project datasets entails stringent p-value thresholds below
5.0 9 10
-8 for signiﬁcant association. These p-value
thresholds are useful reference for GWAS based on the
genotype imputation using genotypes from HapMap and
1000 Genomes as reference sample.
We also estimated potential effective number of SNPs
within known genes. Gene regions were deﬁned according
to the reference genome coordinates (GRCh37) of its
transcripts with 2000 bp extension at both sides. The
RefGene dataset was used in this analysis, including 37,322
transcripts of 22,610 genes. Table 5 lists the estimated
effective number of SNPs and signiﬁcance thresholds in the
Table 3 Estimated effective number of SNPs and p-value thresholds using the HapMap CEU sample
Array Name #SNP Effective ratio p-value thresholds*
In total In
HapMap
Me Signiﬁcant
association
Highly signiﬁcant
association
Illumina HumanHap Omni2.5 2,450,000 969,415 544,311 0.561 3.63E-08 7.27E-10
1 M 1,199,187 964,612 513,911 0.533 7.83E-08 1.57E-09
650Y 660,557 609,860 393,752 0.646 1.17E-07 2.34E-09
p610-Quad 598,821 561,716 374,316 0.666 1.25E-07 2.51E-09
p550-Duo 561,122 540,047 370,501 0.686 1.30E-07 2.60E-09
CNV370 353,188 338,660 258,305 0.763 1.86E-07 3.71E-09
300-Duo 318,117 317,804 251,244 0.791 1.99E-07 3.98E-09
Affymetrix array Array 6.0 934,968 783,702 388,751 0.496 1.08E-07 2.16E-09
Array 5.0 443,816 384,423 211,592 0.550 2.05E-07 4.09E-09
250 K Nsp 262,264 227,290 141,440 0.622 3.06E-07 6.13E-09
250 K Sty 238,304 204,969 136,228 0.665 3.16E-07 6.31E-09
50 K Hind 240 56,936 48,917 38,773 0.793 1.11E-06 2.22E-08
50 K Xba 240 58,625 53,624 41,219 0.769 1.11E-06 2.22E-08
Merged illumina arrays 3,048,319 1,316,091 617,409 0.469 3.50E-08 6.99E-10
Merged affymetrix arrays 1,011,854 853,412 404,187 0.474 1.04E-07 2.09E-09
* p-value threshold is equal to the FWER/(Total number of SNPs 9 effective ratio)
Table 4 Estimated effective number of SNPs and genome-wide signiﬁcance thresholds
#SNP* Me Effective ratio p-value thresholds
Signiﬁcant association Highly signiﬁcant association
HapMap JPT panel 2,509,881 664,279.75 0.26 7.53E-08 1.51E-09
CHB panel 2,554,939 693,418.45 0.27 7.21E-08 1.44E-09
CEU panel 2,776,528 820,888.14 0.30 6.09E-08 1.22E-09
YRI panel 3,114,362 1,452,799.72 0.47 3.44E-08 6.88E-10
1000 Genomes ASN (Asian) 5,367,975 1,442,762.66 0.27 3.47E-08 6.93E-10
EUR (European) 5,730,196 1,634,900.82 0.29 3.06E-08 6.12E-10
AFR (African) 7,961,101 3,091,723.20 0.39 1.62E-08 3.23E-10
*In the 1000 Genomes dataset, 50.4, 51.9 and 53.2% SNPs with minor allele frequency below 0.05 were ﬁltered out in the ASN, EUR and AFR
panels, respectively
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123datasets of 1000 Genomes Project. The effective ratios in
the gene regions are slightly higher than those in the whole
genome. The p-value thresholds for SNPs in gene regions
are roughly twice than that for the whole genome SNPs,
back to a level close to 5 9 10
-8.
As expected from known LD patterns of populations
worldwide (Frazer et al. 2007), the effective ratio in the
Asia population is smaller than that in the European popu-
lation and the African population has the largest effective
ratio in both the HapMap and 1000 Genomes Project
datasets. In principle, the effective ratio measures the
average LD degree between SNPs in a marker set. A lower
effective ratio is resulted from higher degree and/or longer-
range of LD between markers. Given the same set of
markers, a larger Re may imply, on average, more miosis
and recombination evens per genome happened in a pop-
ulation as a result of longer population history. Therefore,
the largest effective ratio in the African population also
indirectly supports the longest history of this population
and is consistent with the ‘Out of Africa’ event hypothesis
(Tishkoff et al. 1996; Reich et al. 2001). Correspondingly,
the required p-value threshold for signiﬁcant association in
the African population is the more stringent those in the
Asian and European population.
A software tool to estimate Me and type I error
We have implemented the proposed measure of effective
number of independent tests and the improved Bonferroni
correctionprocedureinasoftwaretoolnamedgenetictype1
error calculator (GEC, http://statgenpro.psychiatry.hku.hk/
gec/). Users can input actual genotype data [in either the
conventional linkage pedigree format or PLINK binary
format (Purcell et al. 2007)] or the HapMap LD data into
GECtoquicklycalculateMeofthewholegenomeoratsome
speciﬁed genomic regions. Table 6 lists the running time
GEC took to estimate Me by the proposed method on 6
IlluminagenotypingarraysusingHapMapCEULDdata.Ifa
setofSNPpvaluesforgeneticassociationtestsisinput,GEC
will straightforwardly report the signiﬁcant SNPs according
to the improved Bonferroni correction procedure. GEC has
both user-friendly command line and web-based graphic
online interface.
Discussion
Inthepresentstudy,weproposedamorerobustmeasureofthe
effective number of independent tests, Me,t oc o n t r o lF W E R
for genetic association studies. Compared with previous
methods (Gao et al. 2008;L ia n dJ i2005;M o s k v i n aa n d
Schmidt 2008;N y h o l t2004; Galwey 2009), our measure is
morerobusttovariableLDpatternsinrealdatasets.Moreover,
the new measure is additive across multiple distinct LD
blocks. Capitalizing on this property, we developed a divide-
and-conquer algorithm to handle large datasets, which can
substantiallyrelievethecomputationalburdenwhenscanning
millions of SNPs by avoiding calculating eigenvalues of the
massive correlation matrix. We have demonstrated that this
new method yields correct type I error rates and behaves
similarly to the gold standard of permutation.
Pe’er et al. (2008) estimated the multiple testing burden
in GWAS through simulation studies using data on the
HapMap ENCODE regions to emulate an inﬁnitely dense
map, analogous to the Lander and Kruglyak approach for
linkage analysis (Lander and Kruglyak 1995), and arrived
at the commonly accepted genome-wide signiﬁcance
threshold of 5 9 10
-8. Similarly, by subsampling geno-
types at increasing density and extrapolating to inﬁnite
density, Dudbridge and Gusnanto, 2008) estimated the
genome-wide signiﬁcance threshold to be about
7.2 9 10
-8. We noted that for 12 arrays widely used by
previous GWAS, the recommended threshold for a
Table 5 Estimated effective number of SNPs and signiﬁcance thresholds in gene regions
#SNP* Me Effective ratio p-value thresholds
Signiﬁcant association Highly signiﬁcant association
ASN (Asian) 2,427,784 675845.93 0.28 7. 40E-8 1.48E-9
EUR (European) 2,591,410 765,693.14 0.30 6.53E-8 1.31E-9
AFR (African) 3,603,810 1,448,010.91 0.40 3.45E-8 6.91E-10
*51.0, 52.5 and 53.8% SNPs with minor allele frequency below 0.05 were excluded in the ASN, EUR and AFR panels, respectively
Table 6 The running time GEC need to scan various genotyping
arrays
Array name #SNP Running time (min)
a
1 M-Duo 1,199,187 *7.8
650Y 660,557 *3.1
p610-Quad 598,821 *2.7
p550-Duo 561,122 *2.5
CNV370 353,188 *1
300-Duo 318,117 *0.9
The conﬁguration of the computer doing the test is
Intel(R) Xeon(R) X5670 @ 2.97 GHz, and Ubuntu 11.04 64bit; One
GB maximal memory was set for GEC
a The time needed to read HapMap LD data was also included
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123genome-wide error rate of 0.05, 5.0 9 10
-8, is conserva-
tive. For some studies, using arrays of *500,000 or
600,000 SNPs, a p-value threshold of *10
-7 can be safely
adopted without inﬂation of type I error. However, for
GWAS using one of the latest Illumina arrays, Human-
Omni2.5, a threshold as stringent as 5 9 10
-8 or even
slightly smaller is needed. This is also true for GWAS
employing imputed common SNPs based on HapMap data.
For GWAS with several million imputed SNPs from the
1000 Genomes Project dataset, a slightly more stringent p-
value threshold (10
-8) is necessary. However, if one only
examines the imputed SNPs within known genes, the
threshold 5.0 9 10
-8 can be used.
As previously noted (Pe’er et al. 2006; Hao et al. 2008),
GWAS employing Affymetrix arrays allow use of a less
stringent p-value threshold than those employing Illumina
with similar amount of markers because Affymetrix ran-
domly selected their SNPs while Illumina used a tagging
approach in designing their arrays. Consistent with previ-
ous reports (Barrett and Cardon 2006; Pe’er et al. 2008),
the multiple-testing burden for a sample from Japanese and
Chinese populations is less heavy than that for a sample
from Caucasian and African populations. Hence, the exact
thresholds of individual GWAS slightly vary across
genotyping platforms and sampling populations. We pro-
vided a user friendly tool, GEC, to quickly calculate exact
genome-wide thresholds.
The effective ratio, Re, we proposed can aid in marker
selection for genetic association study design as well.
Undoubtedly, a design with Re close to 0 is not cost-efﬁ-
cient because this implies that most typed markers will be
redundant and little independent information will be
obtained. The larger the Re is, the more independent
genotype information the SNP marker set will have.
Meanwhile, it should be noted that solely using Re to
evaluate a design may not be sufﬁcient. It is possible that
only one of two imperfectly correlated markers is in strong
LD with an untyped disease susceptibility locus (DSL).
Exclusion of one marker can deﬁnitely increase the Re but
can result in a loss of statistical power if the only marker in
strong LD with a DSL is removed. Therefore, there is not a
perfect relationship between Re and statistical power.
In the present paper, we did not investigate the perfor-
mance of the proposed method in an imputed GWAS
dataset. The imputation quality, which is often related to
imputation quality thresholds employed to clean the data-
set, imputation algorithms and even matching degree
between the study sample and reference panels, may affect
the estimation of Me in an imputed genotype dataset. If the
quality of imputed genotypes are poor and the pair-wise
LD between SNPs calculated by the imputed genotypes is
largely different from that by actual genotypes, the esti-
mation of Me using the imputed dataset will be not reliable.
On the other hand, if the imputation quality is good and the
pair-wise LD between SNPs calculated according to the
imputed genotypes is very similar to that by actual geno-
types, the proposed method can be safely applied to esti-
mate the Me in the imputed GWAS datasets. In the present
study, we estimated the Me in the public datasets (including
the HapMap Project panels and 1000 Genomes Project
panels) which are widely used as reference panels for
GWAS imputation. The Me and p-value thresholds in these
reference panels can be regarded as reference boundaries
for the imputed GWAS datasets. In practice, one can
employ our tool, GEC, to quickly estimate the Me in an
speciﬁc imputed GWAS datasets given the imputation
quality is good.
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